Loading...
Loading...
Abbott Laboratories
ABT reported a 50% drop in its third-quarter earnings and lifted its quarterly dividend by 57% to $0.22 per share.
Abbott's quarterly profit fell to $966 million, or $0.61 per share, from $1.94 billion, or $1.21 per share, in the year-ago quarter. Excluding one-time items, its adjusted earnings from continuing operations rose to $0.55 per share, beating analysts' estimates of $0.51 per share.
Its revenue rose 2% to $5.37 billion, versus analysts' estimates of $5.39 billion.
Abbott shares rose 1.60% to $34.25 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in